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Abstract
A hallmark of diabetes is the loss of physical or functional β cell mass. Alterations in β cell microRNA
(miRNA) profiles have been described in diabetes. MiRNAs have also been shown to serve as important
regulators of β cell development and function, implicating them in β cell dysfunction during diabetes
development. Our lab has previously demonstrated that β cell microRNA 21 (miR-21) is increased in
models of diabetes. However, a comprehensive analysis of the β cell effects of miR-21 remain poorly
defined, and the effects of miR-21 on in vivo glucose homeostasis have never been explored. To this end,
we performed a comprehensive in silico analysis of bioinformatics databases to identify potential β cell
targets of miR-21, which yielded multiple targets in the Transforming Growth Factor Beta 2 (Tgfb2) and
Fibroblast Growth Factor Receptor 3 (Fgfr3) pathways associated with regulation of differentiation. We
hypothesize that β cell miR-21 plays a critical role in inhibiting β cell function and inducing loss of β cell
identity. To validate targets in vitro, we developed a model whereby miR-21 is upregulated using a dose
dependent lentiviral Tetracycline-on system in INS1 cells. Overexpression of miR-21 led to a reduction in
expression levels of several members of the Tgfb2 and Fgfr3 pathways as well as multiple transcription
factors associated with β cell function and identity, and an increase in aldehyde dehydrogenase transcripts,
consistent with β cell dedifferentiation. To verify direct interactions between miR-21 and candidate target
mRNAs, a biotin pulldown experiment was performed using a 3’ biotinylated mature miR-21 construct and
a 3’ biotinylated cel-miR-67 control construct. Several mRNAs associated with β cell identity were enriched
in the pulldown, indicating a direct interaction with miR-21. Lineage tracing was performed within an in
vivo zebrafish model of β cell specific oxidative stress in which β cells expressed a nuclear GFP signal.
Whole body knock down of miR-21 by morpholino microinjection showed a protective effect in stressed β
cells and rescued against a dedifferentiated phenotype. To test the effect of miR-21 on glucose tolerance in
vivo, inducible β cell specific knockout (βmiR-21KO) and overexpression (βmiR-21) mice were generated
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by crossing Ins1tm1(CreERT2)Thor mice with miR-21 floxed mice and miR-21-CAG-Z-EGFP mice,
respectively. When compared to littermate controls, intraperitoneal glucose tolerance tests (IPGTT)
exhibited hyperglycemia in βmiR-21 mice and euglycemia in βmiR-21KO mice. Metabolic studies,
including glucose stimulated insulin secretion (GSIS) and insulin tolerance tests (ITT) are ongoing in our
mouse models. Our results implicate miR-21 as a regulator of β cell dedifferentiation during diabetes
development.
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